Financhill
Sell
16

KMRSF Quote, Financials, Valuation and Earnings

Last price:
$25.00
Seasonality move :
0%
Day range:
$25.00 - $25.00
52-week range:
$25.00 - $25.00
Dividend yield:
5.92%
P/E ratio:
10.43x
P/S ratio:
0.59x
P/B ratio:
0.99x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$1.9B
Revenue:
$3.7B
EPS (TTM):
$2.40
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $3B $2.8B $3.2B $3.8B $3.7B
Revenue Growth (YoY) -2.78% -6.87% 14.16% 18.97% -2.69%
 
Cost of Revenues $1.5B $1.4B $1.7B $2.1B $1.9B
Gross Profit $1.4B $1.4B $1.5B $1.6B $1.8B
Gross Profit Margin 47.93% 50.89% 46.15% 43.05% 48.16%
 
R&D Expenses $33.9M $33M $33.5M $34.6M $37M
Selling, General & Admin $201.6M $193.9M $222.8M $248.3M $234.8M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.2B $1.2B $1.3B $1.3B $1.3B
Operating Income $215.8M $244.6M $201.1M $355.2M $473M
 
Net Interest Expenses $43M $37.5M $32.2M $39.5M $39.7M
EBT. Incl. Unusual Items $173.2M $206.7M $169.5M $325M $316.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $42.8M $49.1M $33.4M $72.2M $87.4M
Net Income to Company $130.4M $157.6M $136.3M $252.8M $228.8M
 
Minority Interest in Earnings -$7.1M -$7.7M -$8.4M -$8.4M -$13.2M
Net Income to Common Excl Extra Items $123.4M $149.9M $127.9M $244.3M $215.5M
 
Basic EPS (Cont. Ops) $1.61 $1.96 $1.68 $3.18 $2.81
Diluted EPS (Cont. Ops) $1.61 $1.96 $1.66 $3.16 $2.77
Weighted Average Basic Share $76.3M $76.4M $76.5M $76.7M $76.8M
Weighted Average Diluted Share $76.5M $76.7M $76.9M $77.1M $77.5M
 
EBITDA $425.3M $465.5M $441M $586M $585.2M
EBIT $214.9M $240.1M $204.1M $364.3M $364.7M
 
Revenue (Reported) $3B $2.8B $3.2B $3.8B $3.7B
Operating Income (Reported) $215.8M $244.6M $201.1M $355.2M $473M
Operating Income (Adjusted) $214.9M $240.1M $204.1M $364.3M $364.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $697.8M $816.7M $979.1M $902.3M $800.2M
Revenue Growth (YoY) -9.03% 17.05% 19.88% -7.84% -11.31%
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $628.7M $749.9M $893.9M $788.5M $694.4M
Operating Income $69.1M $66.9M $85.1M $113.8M $105.8M
 
Net Interest Expenses $8.8M $9.2M $7.5M $10.8M $7.6M
EBT. Incl. Unusual Items $60.3M $57.4M $77.7M $103M $98.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14.7M $10.7M $17M $21M $24.4M
Net Income to Company $50.8M $45M $55.6M $81.6M $77.2M
 
Minority Interest in Earnings -$2M -$2.2M -$2.4M -$3.8M -$4M
Net Income to Common Excl Extra Items $43.6M $44.5M $58.3M $78.1M $69.9M
 
Basic EPS (Cont. Ops) $0.56 $0.59 $0.77 $1.02 $0.90
Diluted EPS (Cont. Ops) $0.56 $0.59 $0.77 $1.00 $0.90
Weighted Average Basic Share $76.5M $76.6M $76.7M $76.8M $77M
Weighted Average Diluted Share $76.7M $76.9M $77.2M $77.6M $77.6M
 
EBITDA $128.4M $129.2M $138.3M $171.2M $157.2M
EBIT $69.1M $66.6M $85.1M $113.8M $105.9M
 
Revenue (Reported) $697.8M $816.7M $979.1M $902.3M $800.2M
Operating Income (Reported) $69.1M $66.9M $85.1M $113.8M $105.8M
Operating Income (Adjusted) $69.1M $66.6M $85.1M $113.8M $105.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.8B $3.1B $3.6B $3.8B $3.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1B $1.4B $1.7B $1.2B $969.6M
Operating Income $220M $228.7M $248.3M $487M $431.4M
 
Net Interest Expenses $38.6M $30.3M $36.4M $49.2M $27.9M
EBT. Incl. Unusual Items $181.9M $197.8M $212.7M $446.7M $287.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $43.9M $43.4M $43.5M $96M $86.4M
Net Income to Company $144M $148.2M $162.6M $361.9M $201.9M
 
Minority Interest in Earnings -$7.3M -$8.7M -$8.2M -$11.8M -$14.5M
Net Income to Common Excl Extra Items $130.7M $145.5M $161.4M $338.7M $186.4M
 
Basic EPS (Cont. Ops) $1.69 $1.91 $2.10 $4.42 $2.42
Diluted EPS (Cont. Ops) $1.69 $1.91 $2.08 $4.37 $2.40
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $434.6M $465.2M $475.9M $715.4M $528M
EBIT $219.1M $223.8M $251.4M $495.6M $324.1M
 
Revenue (Reported) $2.8B $3.1B $3.6B $3.8B $3.3B
Operating Income (Reported) $220M $228.7M $248.3M $487M $431.4M
Operating Income (Adjusted) $219.1M $223.8M $251.4M $495.6M $324.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2B $2.3B $2.8B $2.8B $2.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.9B $2.2B $2.5B $2.4B $2.1B
Operating Income $197.4M $182.7M $228.5M $363.3M $322.1M
 
Net Interest Expenses $28.5M $21.4M $25.8M $35.5M $23.7M
EBT. Incl. Unusual Items $169M $161.1M $202.8M $327.6M $298.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $40.6M $35.2M $44.8M $69.2M $68.3M
Net Income to Company $133.5M $124.2M $150.5M $259.6M $232.7M
 
Minority Interest in Earnings -$5.6M -$6.7M -$6.5M -$9.8M -$11.1M
Net Income to Common Excl Extra Items $122.9M $119.2M $151.8M $248.4M $219M
 
Basic EPS (Cont. Ops) $1.60 $1.55 $1.97 $3.25 $2.83
Diluted EPS (Cont. Ops) $1.60 $1.55 $1.97 $3.21 $2.83
Weighted Average Basic Share $229.2M $229.6M $230M $230.3M $230.9M
Weighted Average Diluted Share $230.1M $230.7M $231.2M $232.6M $232.9M
 
EBITDA $362.3M $363.3M $397.1M $529.6M $472.2M
EBIT $197.4M $182.4M $228.6M $363M $322.2M
 
Revenue (Reported) $2B $2.3B $2.8B $2.8B $2.4B
Operating Income (Reported) $197.4M $182.7M $228.5M $363.3M $322.1M
Operating Income (Adjusted) $197.4M $182.4M $228.6M $363M $322.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $160.3M $196.2M $161.2M $268.7M $444.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $345.5M $354.8M $422.3M $482.2M $426.9M
Inventory $282.8M $280.7M $362.4M $442.4M $290.1M
Prepaid Expenses $11.4M $21M $44M $30.3M $30.8M
Other Current Assets -- -- -- -- --
Total Current Assets $897.1M $956.4M $1.1B $1.4B $1.6B
 
Property Plant And Equipment $1.3B $1.4B $1.4B $1.3B $1.2B
Long-Term Investments -- -- -- -- --
Goodwill $577.8M $620M $582M $547.5M $531.6M
Other Intangibles $106.9M $95.9M $75.5M $65.3M $56.5M
Other Long-Term Assets -- -- -- -- --
Total Assets $3.2B $3.4B $3.6B $3.9B $3.9B
 
Accounts Payable $210.8M $221.6M $323.2M $314M $250.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $31.8M $33.2M $32.5M $33.1M $30.5M
Other Current Liabilities $43.6M $33.2M $49.7M $70.2M $49M
Total Current Liabilities $810.6M $829.4M $895.5M $960.4M $1.1B
 
Long-Term Debt $708.1M $774.5M $757.1M $772.2M $576.9M
Capital Leases -- -- -- -- --
Total Liabilities $1.9B $2B $2B $2.1B $2B
 
Common Stock $248.5M $272.8M $251.1M $237.9M $245.2M
Other Common Equity Adj -- -- -- -- --
Common Equity $1.4B $1.5B $1.5B $1.8B $1.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $14.9M $16.2M $15.7M $15.8M $21.4M
Total Equity $1.4B $1.5B $1.5B $1.8B $1.9B
 
Total Liabilities and Equity $3.2B $3.4B $3.6B $3.9B $3.9B
Cash and Short Terms $160.3M $196.2M $161.2M $268.7M $444.9M
Total Debt $918.9M $980.8M $968.4M $936.1M $902.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $218M $213.9M $170.9M $426.7M $484.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $400.8M $499.6M $689.4M $525.9M $485.7M
Inventory $301M $376.2M $466M $367.8M $336.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $940.4M $1.1B $1.4B $1.4B $1.4B
 
Property Plant And Equipment $1.3B $1.3B $1.2B $1.3B $1.2B
Long-Term Investments -- -- -- -- --
Goodwill $598.2M $593.5M $514.1M $543.1M $538.3M
Other Intangibles $95.5M $78.4M $60M $58M $46M
Other Long-Term Assets -- -- -- -- --
Total Assets $3.3B $3.5B $3.7B $3.7B $3.6B
 
Accounts Payable $430.4M $592M $673.1M $602.7M $576.8M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $791.5M $893.2M $1B $1B $931.3M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $1.9B $2B $2.1B $1.9B $1.7B
 
Common Stock $260.4M $257.3M $218M $234.8M $247.7M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $13.9M $14.2M $12M $16.5M $19.1M
Total Equity $1.4B $1.5B $1.6B $1.8B $2B
 
Total Liabilities and Equity $3.3B $3.5B $3.7B $3.7B $3.6B
Cash and Short Terms $218M $213.9M $170.9M $426.7M $484.3M
Total Debt $1.1B $1.1B $1.1B $1B $830.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $130.4M $157.6M $136.3M $252.8M $228.8M
Depreciation & Amoritzation $210.4M $225.4M $236.9M $221.8M $220.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $22.9M $3.9M -$92.1M -$100.3M $20.6M
Change in Inventories $21.7M $2.5M -$118.9M -$105.8M $105.7M
Cash From Operations $432.4M $427.9M $260.5M $422.2M $591.1M
 
Capital Expenditures $225.1M $223.4M $199.7M $208.7M $221.8M
Cash Acquisitions $1.7M -$3M -$1.2M -- $7.7M
Cash From Investing -$219.8M -$230M -$192.7M -$187.7M -$212.9M
 
Dividends Paid (Ex Special Dividend) -$97.3M -$104.8M -$112.8M -$93.8M -$103.1M
Special Dividend Paid
Long-Term Debt Issued $44.9M -- $236.6M $206.6M $216.5K
Long-Term Debt Repaid -$123.5M -$62.8M -$115.1M -$213.9M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$11.9M -$12.2M $118.3K $105.5K --
Cash From Financing -$216.3M -$172.3M -$94.1M -$122.8M -$207.1M
 
Beginning Cash (CF) $162.2M $163.4M $188.7M $150.2M $271.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.7M $25.6M -$26.3M $111.7M $171.1M
Ending Cash (CF) $160.2M $182.2M $168.5M $264.3M $435.8M
 
Levered Free Cash Flow $207.2M $204.5M $60.8M $213.5M $369.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $50.8M $45M $55.6M $81.6M $77.2M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $144.7M $101.2M $113.9M $188.1M $128.1M
 
Capital Expenditures $63.2M $39.8M $40M $59.1M $40M
Cash Acquisitions -$177K -$1.2M -- $205.2K -$7.3M
Cash From Investing -$62.6M -$40.8M -$39.4M -$58.9M -$48.6M
 
Dividends Paid (Ex Special Dividend) -$7.8M -$4.1M -$4.4M -$7.9M -$9.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -$5.2M -$919K -$109K --
Long-Term Debt Repaid $11.5M $2.5M $3.1M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$18.4M -$59M -$106.5K $217.8K -$4.6M
Cash From Financing -$18.4M -$14.8M -$47.9M -$16.9M -$22.9M
 
Beginning Cash (CF) $147.1M $175.1M $156.9M $326.6M $414.1M
Foreign Exchange Rate Adjustment -$3.6M $875.3K -$125.5K $331.1K -$3.3M
Additions / Reductions $63.8M $45.6M $26.5M $112.3M $56.5M
Ending Cash (CF) $217.2M $217.4M $175.2M $438.9M $476.9M
 
Levered Free Cash Flow $81.5M $61.4M $73.9M $129M $88M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $144M $148.2M $162.6M $361.9M $201.9M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $428.3M $325.3M $242.6M $725M $492.8M
 
Capital Expenditures $376.7M $182.9M $197.6M $243.9M $183.7M
Cash Acquisitions $134M -$1.1M -$4.1K $8.5M $152.9M
Cash From Investing -$246.9M -$188.5M -$184.4M -$218.9M -$81.1M
 
Dividends Paid (Ex Special Dividend) -$57.5M -$108M -$104.5M -$102.8M -$113.4M
Special Dividend Paid
Long-Term Debt Issued -- -- -- $190.6M --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$30.3M -$52.7M $59M -- -$220.2M
Cash From Financing -$83.4M -$142.5M -$85.9M -$249.9M -$374.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $98M -$5.7M -$27.6M $256.3M $37.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $51.7M $142.4M $45.1M $481.2M $309.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $133.5M $124.2M $150.5M $259.6M $232.7M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $267M $164.4M $146.5M $449.3M $351.1M
 
Capital Expenditures $151.6M $111.1M $108.9M $144M $105.9M
Cash Acquisitions -$3M -$1.2M -- $8.5M $153.8M
Cash From Investing -$153.8M -$112.2M -$103.9M -$135M -$3.2M
 
Dividends Paid (Ex Special Dividend) -$56.8M -$60M -$51.8M -$60.9M -$71.2M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $235.8M $16M -- --
Long-Term Debt Repaid -- -$114.7M -$53.2M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$18.4M -$58.8M -- $217.8K -$220M
Cash From Financing -$56.6M -$26.8M -$18.6M -$145.8M -$312.8M
 
Beginning Cash (CF) $492.4M $611.9M $490.1M $889.2M $1.5B
Foreign Exchange Rate Adjustment -$6.8M $4M $7.8M -$2.6M -$989.8K
Additions / Reductions $56.6M $25.3M $24M $168.5M $35.1M
Ending Cash (CF) $551.7M $637.1M $505.4M $1.1B $1.5B
 
Levered Free Cash Flow $115.4M $53.3M $37.6M $305.3M $245.1M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 9.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 13.45% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock